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 INTRODUCTION
 Th e gut microbiota comprises thousands of bacterial species with 
a collective gene pool 150 times larger than the human genome 
with tremendous functional diversity ( 1 ). A gut microbiota, 
characteristic of Crohn’s disease (CD), has been repeatedly 
described ( 2,3 ). Although much progress has been made in 
understanding interactions between the gut microbiota and 
intestinal immune system and their involvement CD etiology 
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( 4 ), it remains unclear whether changes in microbiota precede or 
follow CD onset. Th us far, all studies exploring the colonic 
microenvironment of CD patients have been of cross-sectional 
and hence unable to address reverse causality ( 2,3 ). Assessing, 
during the course of disease modifying treatment, serial changes 
in the gut microbiota, particularly organisms associated with 
colonic infl ammation, will off er better insights into the role of gut 
bacteria or their products in the etiology of CD. Such a study has 
not been performed before.
 Exclusive enteral nutrition (EEN) is an established treatment 
in active pediatric CD ( 5 ). In contrast to biologics, the mode of 
EEN action remains unknown. We have recently shown that EEN 
treatment in children with active CD induced reduction in numbers of 
presumptively protective gut bacterial species (e.g.,  Faecalibacterium 
prausnitzii ) and metabolites (e.g., butyrate) that were paradoxically 
associated with disease improvement ( 6 ). Th ese intriguing observa-
tions in conjunction with the simple nutrient and food ingredients 
of EEN make it plausible to speculate that EEN works by modulating 
the gut microbiota. Assessing changes in the gut microbiota during 
a course of EEN can off er clues to which bacteria and/or their 
metabolites may be implicated in the etiology of CD.
 Most previous studies have explored the gut microbiota in 
CD by targeting certain limited microbial species and bacterial 
metabolites for which primers/probes were available ( 6,7 ). Recent 
advances in sequencing technologies allow a hypothesis-free 
assessment of the entire microbial community dynamics. Using 
massively parallel ultra-deep sequencing and state-of-the-art com-
putational approaches, we have characterized microbial commu-
nity structure and genetic functional capacity in fecal samples from 
children with active CD and healthy controls by both targeting the 
bacterial 16S  rRNA genes and employing shotgun metagenomics. 
Using the same methodology, we studied, for the fi rst time, the 
association of the pediatric CD microbiota with intestinal infl am-
matory markers and changes before, during, and aft er induction 
treatment with EEN.
 METHODS
 Subjects
 Fecal samples were collected from 23 children (males:  n =13; 
6.9–14.7 years) with active CD (Montreal classifi cation; Disease 
location: L2,  n =3; L2+L4,  n =4; L3,  n =3; L3+L4,  n =13; Disease 
behavior: B1,  n =20; B2,  n =2; B3,  n =1) and for 15 of these (11 newly 
diagnosed), with at least two consecutive samples, during 8 weeks 
of EEN (Modulen, Nestle, Vevey, Switzerland) as described previ-
ously ( 6 ). A maximum of fi ve serial samples were collected per 
patient. Th e fi rst sample (A) was collected before or within 6 days 
of EEN initiation (89% collected within 4 days), two during EEN 
(B:~16 & C:~32 days), and one close to end of treatment (D:~54 
days). A fi nal sample (E) was collected when patients returned to 
habitual diet (E:~63 days aft er EEN). Th e number of participants 
with 1, 2, 3, 4, and 5 samples were 5, 3, 3, 2, and 10, respectively. 
Two fecal samples were collected, at least 2 months apart, from 
21 healthy children (males:  n =12; 4.6–16.9 years) with no known 
family history of infl ammatory bowel disease as a control group. 
Th e healthy children were recruited from the local community via 
poster advertisement. No participant had received antibiotics for 
3 months prior to the study. Concomitant treatment was prospec-
tively recorded ( Supplementary Table S1 online).
 Serum albumin, CRP, erythrocyte sedimentation rate, and fecal 
calprotectin ( 8 ) were measured and Paediatric Crohn’s Disease 
Activity Index (PCDAI) ( 9 ) calculated at EEN initiation, end 
of EEN, and when patients returned to habitual diet. All these 
disease activity indices signifi cantly decreased, and 62% of 
participants achieved clinical remission (PCDAI <10) at the end 
of EEN ( Supplementary Table S1 ).
 Th is study received ethics approval by the Yorkhill Research 
Ethics Committee (05/S0708/66). Carer and patients provided 
written consent.
 16S  rRNA gene sequencing
 Sequencing of 16S  rRNA gene was performed to characterize 
microbial community composition. Detailed description of the 
16S rRNA sequencing is available in  Supplementary Methods . 
Briefl y, bacterial DNA was isolated using the chaotropic method 
( 6 ). 16S  rRNA gene sequencing of the V4 region was performed 
on the MiSeq (Illumina, Essex, UK) platform using 2×250 bp 
paired-end reads. Th e V4 region was amplifi ed using fusion Golay 
adapters barcoded on the reverse strand.
 Shotgun metagenome sequencing
 Shotgun metagenome samples, indicative of microbiota genetic 
functional capacity, were prepared for 69 of the samples (CD, 
 n =56; Healthy,  n =13) with the Nextera XT Prep Kit (Illumina, 
FC-131–1096, UK) and the Illumina dual-barcoding Nextera XT 
Index kit (Illumina, FC-131–1002, UK). Detailed description of the 
shotgun metagenome sequencing is available in  Supplementary 
Methods . Clusters were generated on-board a HiSeq 2500 
(Illumina) instrument and sequencing performed using TruSeq 
Rapid SBS Kit reagents (Illumina, FC-402–4001, FC-402–4002). 
Sequencing was performed following a paired-end 150 cycle recipe.
 Bioinformatics
 Detailed description of bioinformatics analysis is available as 
 Supplementary File ( Supplementary Methods ). In brief, 
microbiota composition was characterized at multiple levels of 
resolution using genus, operational taxonomic unit (OTU), and 
‘oligotyping’ assignments from the 16S rRNA sequencing, the lat-
ter two approximating the species level. Shotgun metagenomics 
reads were used for species taxonomic profi ling using MetaPhlAn 
and assignments to functional modules, orthologs, and pathways 
through alignment to Kyoto Encyclopedia of Genes and Genomes 
(KEGG) using HUMAnN ( 10 ). Th e latter are indicative of the 
genetic functional capacity of the entire gut microbiota.
 Statistics
 Statistical analysis was performed on log-transformed data, and 
Benjamini–Hochberg false-discovery rate was used to account 
for multiple comparisons. We used the Adonis function of 
the R vegan package to determine the overall amount and sig-
© 2015 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
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nifi cance of diff erences between controls and CD before EEN. 
Each marker was tested independently using Kruskal–Wallis. 
For the 16S rRNA markers (genera, OTU, and oligotypes), only 
those with mean relative abundance >0.01% were tested. For the 
metagenome data (MetaPhlAn species and HUManN KEGG 
modules and orthologs), we used all markers as there were fewer 
of them. We used a similar procedure as for comparisons between 
controls and CD children to test for the changes between sample 
D (end of EEN) and E (habitual diet) for 16S rRNA and metage-
nome markers.
 For CD subjects with two or more samples and who were still 
on or had just stopped EEN treatment (≤3 days of treatment end), 
individual marker data regressed against EEN days with a subject-
specifi c intercept using the GLM function. Th us, any confounding 
eff ect of diff erent sample collection times, particularly aft er EEN 
initiation and completion, was naturally accounted for within the 
analysis.
 We correlated the log-transformed relative abundance of each 
marker against fecal calprotectin using Kendall’s rank correlation. 
For 16S rRNA markers, we tested only those with mean relative 
abundance >0.01% but for metagenome markers used all markers. 
All markers with  P -value <0.01 were included in stepwise multi-
variate regression of calprotectin as a function of all these markers.
 RESULTS
 We characterized the microbial community using 16S  rRNA 
gene sequencing in 117 samples ( n =78 CD participants and  n =39 
healthy controls) and shotgun metagenomics in 65 ( n =53 from 
CD participants and  n =12 controls). Only samples with greater 
than 5,000 fi ltered and overlapped 16S rRNA or 100,000 shotgun 
metagenome reads were included.
 Bacterial community structure (16S  rRNA gene and shotgun 
metagenomics)
 Controls vs. CD patients before EEN .  Th e mean Shannon diversity, 
a measure of gut microbiota richness and evenness, was higher in 
controls than CD children prior to EEN (Controls vs. CD: 10.23 
vs. 8.00;  P =0.006;  Figure 1 ). A higher diversity was observed using 
OTU than genus analysis. However, the reduction in diversity 
associated with CD was similar with both approaches ( P =4.2×10 −5 , 
 Supplementary Figure S1 ). In contrast, beta diversity, the variabil-
ity of the OTU community structure between samples, was higher 
for CD children than healthy controls. Th is was apparent from 
 Figure 1 but also using the betadisper function of the R vegan pack-
age. Th e dissimilarity of microbial community structure, among 
groups, expressed with the average Bray–Curtis distance for sam-
ples, was signifi cantly higher in CD children (CD vs. Controls: 
0.4913 vs. 0.4089;  P =0.048). Th is eff ect was more signifi cant using 
OTU analysis (CD vs. Controls: 0.5848 vs. 0.4868;  P <0.001).
 Th e microbial community structure was also diff erent between 
controls and CD patients, with 9.9% of the variation in community 
structure explained by sample groups ( P =0.001). An association 
between age and genus community structure was observed for 
controls ( P =0.033) but not CD children. However, this eff ect was 
weak and swamped by the eff ect that grouping (Controls vs. CD) 
had on genus community structure. Similarly, no diff erence was 
observed ( P -value=0.697) in genus community structure between 
samples of CD patients collected one day before EEN ( n =7) com-
pared with samples collected within 6 days of EEN ( n =10). Th e 
eff ect of disease aff ecting the ileum on community diversity and 
structure was explored and compared with subjects without ileal 
disease, but the diff erence did not reach statistical signifi cance 
( P =0.176).
 Figure 2 displays the relative abundance of the top 20 genera 
present in both CD and healthy controls. In total, 36 genera out 
of 84 (43%) tested diff ered signifi cantly between CD children and 
controls ( Table 1 ). Genera belonging to the Lachnospiraceae were 
more abundant in controls, (e.g.,  Coprococcus, Pseudobutyrivibrio , 
and  Ruminococcus ) as were  Subdoligranum and  Faecalibacterium 
from Clostridiales. In contrast, other members of Clostridiales 
such as  Peptostreptococcus were more abundant in CD children 
( Table 1 ). A number of genera were also more abundant in CD 
children from diverse phyla such as the Actinobacteria member 
 Atopobium or the Proteobacteria member  Escherichia–Shigella 
( Table 1 ). Similar observations resulted from OTU assignments 
( Figure 2 ). Overall, 9.6% of the variation ( P <0.001) was explained 
by group (Controls vs. CD). Th e relative abundance of a total of 
141 OTUs out of 351 (42%) tested diff ered signifi cantly between 
controls and those with CD. Th e 20 most signifi cant are presented 
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 Figure 1 .  Genus Shannon diversity, in richness equivalents ( a ), and 
non-metric multidimensional scaling (NMDS) of operational taxonomic 
unit (OTU) community structures ( b ) for each EEN sample time for the 
Crohn’s disease (CD) children and healthy controls. ( a ) Diversity, in species 
equivalents, decreased during exclusive enteral nutrition (EEN;  P =0.037) 
and was higher in healthy children vs. CD children at time A ( P =0.009). 
( b ) NMDS plot using Bray–Curtis distances of the 3% OTU community 
structures.
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 Figure 2 .  Relative abundance of the 20 most abundant bacterial genera ( a ), operational taxonomic units (OTUs) ( b ), and MetaPhlAn species from shotgun 
metagenome samples ( c ) for each exclusive enteral nutrition (EEN) sample time for the Crohn’s disease (CD) children and healthy controls. OTUs assign-
ments see  Supplementary Table S14. 
 
A:before EEN B:15d C:30d D:60d E:free diet H:healthy controls
Taxa
Taxa
Taxa
Blautia
Lachnospiraceae.Incertae.Sedis
Bifidobacterium
Unknown.Coriobacteriaceae.genus
Subdoligranulum
Akkermansia
Dorea
Bacteroides
Enterococcus
Anaerostipes
Escherichia.Shigella
Faecalibacterium
Streptococcus
Veillonella
Ruminococcus
Peptostreptococcaceae.Incertae.Sedis
Pseudobutyrivibrio
Phascolarctobacterium
Erysipelotrichaceae.Incertae.Sedis
Dialister
Others
OTU_3
OTU_1
OTU_2
OTU_4
OTU_6
OTU_9
OTU_5
OTU_16
OTU_97
OTU_12
OTU_11
OTU_13
OTU_22
OTU_1370
OTU_7
OTU_10
OTU_15
OTU_8
OTU_20
OTU_32
Others
Bifidobacterium_bifidum
Ruminococcus_torques
Blautia_unclassified
Collinsella_aerofaciens
Ruminococcus_gnavus
Enterococcus_faecalis
Bifidobacterium_longum
Bifidobacterium_adolescentis
Dorea_longicatena
Dialister_invisus
Dorea_formicigenerans
Collinsella_intestinalis
Ruminococcus_bromii
Eggerthella_lenta
Ruminococcus_obeum
Eubacterium_rectale
Eubacterium_hallii
Clostridium_scindens
Bacteroides_unclassified
Bifidobacterium_pseudocatenulatum
Others
1.00
a
b
c
0.75
0.50
0.25
0.00
Sample
Sample
Sample
Pr
op
or
tio
ns
A:before EEN B:15d C:30d D:60d E:free diet H:healthy controls1.00
0.75
0.50
0.25
0.00
Pr
op
or
tio
ns
A:before EEN B:15d C:30d D:60d E:free diet H:healthy controls1.00
0.75
0.50
0.25
0.00
Pr
op
or
tio
ns
© 2015 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
5
P
E
D
IA
T
R
IC
S
Fecal Metagenome and Exclusive Enteral Nutrition
 Table 1 .  Relative abundance of bacterial genera in the healthy control group and children with Crohn’s before treatment with exclusive 
enteral nutrition 
 Healthy  Crohn’s disease 
 Genus  Mean  s.e.  Mean  s.e.  P  value  P  value adjusted 
 Decreased in CD 
  Coprococcus  6.54E−03  1.74E−03  4.24E−04  3.64E−04  6.98E−07  2.93E−05 
  Pseudobutyrivibrio  2.35E−02  3.61E−03  3.96E−03  2.59E−03  6.98E−07  2.93E−05 
  Ruminococcus  3.36E−02  4.93E−03  5.00E−03  2.44E−03  1.76E−06  4.92E−05 
  Subdoligranulum  5.84E−02  5.66E−03  1.73E−02  6.69E−03  7.41E−06  1.56E−04 
  Faecalibacterium  2.96E−02  4.23E−03  9.27E−03  3.34E−03  3.14E−04  3.30E−03 
  Lachnospira  6.57E−04  2.14E−04  4.13E−05  3.21E−05  7.48E−04  6.28E−03 
  Clostridium (Clostridiaceae)  6.65E−03  1.14E−03  2.48E−03  9.89E−04  1.35E−03  9.22E−03 
 Alistipes  4.73E−03  1.70E−03  1.90E−03  1.38E−03  1.43E−03  9.22E−03 
 Parabacteroides  1.44E−03  4.56E−04  3.78E−04  2.57E−04  1.89E−03  1.12E−02 
  Atopobium  1.49E−05  5.72E−06  1.53E-03  1.38E−03  2.00E−03  1.12E−02 
  Anaerotruncus  9.79E−04  3.27E−04  4.53E−04  3.43E−04  2.36E-03  1.24E−02 
  Roseburia  5.66E−03  1.05E−03  3.51E−03  1.62E−03  3.10E−03  1.53E−02 
  Turicibacter  1.69E−03  4.75E−04  4.90E−04  2.31E−04  3.84E−03  1.79E−02 
  Anaerostipes  1.74E−02  2.39E−03  7.74E−03  2.15E−03  4.98E−03  2.09E−02 
  Catabacter  2.61E−04  5.04E−05  1.24E−04  5.34E−05  8.64E−03  3.30E−02 
  Biﬁ dobacterium  1.53E−01  1.80E−02  7.90E−02  2.14E−02  9.07E−03  3.31E−02 
  Bilophila  6.75E−04  2.87E−04  7.37E−05  4.43E−05  9.52E−03  3.33E−02 
  Ruminococcaceae Incertae Sedis  1.14E−02  1.25E−03  6.66E−03  1.78E−03  1.05E−02  3.38E−02 
 Unknown  Biﬁ dobacteriaceae genus  1.12E−03  1.36E−04  6.13E−04  1.44E−04  1.27E−02  3.94E−02 
  Slackia  6.81E−04  2.38E−04  7.76E−06  5.68E−06  1.67E−02  5.00E−02 
 Unknown  Coriobacteriaceae genus  4.47E−02  6.81E−03  3.82E−02  1.54E−02  3.19E−02  8.38E−02 
  Dialister  1.91E−02  5.33E−03  4.44E−03  2.07E−03  3.76E−02  9.13E−02 
 Increased in CD 
  Unknown  Ruminococcaceae genus  9.81E−04  9.83E−05  1.05E−02  1.02E−02  9.35E−06  1.57E−04 
 Parvimonas  1.37E−05  5.01E−06  5.08E−04  2.25E−04  8.92E−05  1.25E−03 
 Actinomyces  9.59E-04  2.11E−04  1.09E−02  6.15E−03  2.43E−04  2.91E−03 
 Anaerococcus  2.51E−05  8.11E−06  1.30E−02  9.46E−03  7.04E−04  6.28E−03 
 Peptostreptococcus  9.58E−05  2.58E−05  1.05E−02  5.12E−03  8.43E-04  6.44E−03 
 Lactococcus  3.84E−04  1.30E−04  1.10E−02  1.04E−02  4.49E−03  1.99E−02 
 Escherichia–Shigella  1.57E−03  4.35E−04  4.15E−02  2.19E−02  7.46E−03  2.98E−02 
 Eggerthella  1.23E−03  5.36E−04  6.55E−03  2.40E−03  9.99E−03  3.36E-02 
 Megasphaera  5.95E−05  3.16E−05  3.93E−03  3.36E−03  2.48E−02  7.18E−02 
 Prevotella  1.58E−02  6.67E−03  1.96E−02  1.82E-02  2.70E−02  7.56E−02 
 Gemella  5.97E−05  1.17E−05  1.26E−03  6.96E−04  2.94E−02  7.96E−02 
 Mogibacterium  3.40E−05  9.51E−06  2.59E−04  1.48E−04  3.61E-02  9.13E−02 
 Peptoniphilus  5.58E−05  1.42E−05  3.36E−03  2.12E−03  3.91E−02  9.13E−02 
 Abiotrophia  1.29E−06  7.94E−07  4.27E−04  3.70E−04  3.91E−02  9.13E−02 
 CD, Crohn’s disease. 
 Data are displayed with standard errors and means.  P -values for Kruskal–Wallis tests on the log-transformed data using Benjamini–Hochberg false discovery rate to adjust 
signiﬁ cance values for multiple comparisons. Only genera with a mean abundance >0.01% were tested. 
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in  Supplementary Table S2 . Many OTUs, more abundant in con-
trols, were affi  liated with Lachnospiraceae, (e.g., OTU88; OTU10 
( Pseudobutyrivibrio ); OTU18 ( Ruminococcus )), whereas OTU69 
( Streptococcus ) was more abundant in samples from CD patients 
( Supplementary Table S2 ).
 In-depth analysis of the Lachnospiraceae in 1,191,470 reads 
using oligotyping resulted in 93 high-resolution oligotypes, 
explaining even more of the variation associated with CD children 
compared with controls (12.4%;  P <0.001). Forty-four oligotypes 
(47%) diff ered signifi cantly between the two groups. Th e 20 most 
signifi cant oligotypes are in  Supplementary Table 3 . Th e 
fi ndings of this high-resolution analysis were consistent with those 
observed through the genera and OTU assignments. Oligotypes 
classifi ed as  E. rectale and  Roseburia inulinivorans were more 
abundant in controls, whereas  R. gnavus and  Clostridium clostridi-
oformes were associated with CD.
 For classifi cation of shotgun metagenome reads to species level 
with MetaPhlAn, a tendency for higher mean Shannon diver-
sity was found for controls (CD vs. Controls: 18.49 vs. 14.30; 
 P =0.230,  Supplementary Figure S1 ). Th e two groups explained 
15% of the variation in community structure ( P <1.0×10 −5 ), but at 
the whole community level no diff erences in species proportions 
were observed (R 2 =0.0733,  P =0.476;  Figure S2 online ). In total, 36 
species had a false discovery rate <10% ( Supplementary Table S4 ). 
Th ese results were consistent with other computational approaches 
using 16S rRNA sequencing. Species such as  Bifi dobacterium 
adolescentis ,  Ruminococcus bromii ,  Eubacterium spp. ,  F. prausnitzii , 
 Coprococcus eutactus , and  Subdoligranulum variabile were more 
abundant in controls, whereas in CD children  Streptococcus angi-
nosus ,  Enterococcus faecalis , and  R. gnavus were overrepresented 
along with other species ( Supplementary Table S4 ).
 Impact of EEN on CD .  During EEN, the Shannon diversity, at 
the genus level, decreased ( P =0.037;  Figure 1 ). Th is became 
apparent even aft er 15 days on EEN (sample B) with a minimum 
diversity observed by ~30 days (sample C), a slight recovery 
toward the end of EEN (sample D) and complete recovery to 
pre-treatment levels when patients returned to habitual diet 
(sample E) ( Figure 1 ). When genus diversity was regressed against 
days on EEN, using subject-dependent linear regression, to over-
come any confounding eff ects of the time of sample collection 
during EEN, we found ( Supplementary Figure S2 ) that every 10 
days on EEN 0.6 genus diversity equivalents are lost (coeff  (SE): 
−0.06 (0.012);  P =2.36×10 −5 ). Similar results were observed for 
classifi cation of shotgun metagenome reads to species with 
MetaPhlAn ( P =0.0023) and a trend based on OTU analysis 
( P =0.140;  Supplementary Figure S1 ).
 At the community structure level, EEN made the CD microbial 
community even more dissimilar to that typical of healthy con-
trols ( Figure 1 ). Sample time explained 6.4% of the variation in 
the microbial community structure of CD children ( P =0.094). At 
all points during EEN, there was no diff erence in microbial com-
munity structure between patients with and without ileal disease 
involvement. Changes in the top 20 taxa during EEN are displayed 
in  Figure 2 . Microbial community structure at each EEN sample 
time point was independent of other concomitant treatment or 
whether this was the fi rst or a subsequent EEN course suggesting 
that the observed changes were associated with EEN only.
 When relative abundance of each bacterial taxon, based on 
OTU and genus assignments, was regressed against days on EEN, 
allowing for a subject-dependent intercept, representing diff er-
ent starting abundances in diff erent children, the vast majority of 
signifi cant changes represented a reduction in relative abundance. 
Indeed, of 34 genera that signifi cantly changed, only one,  Lacto-
coccus , increased with EEN ( Table 2 ). Interestingly, some of the 
most negatively impacted genera were those whose abundance was 
already lower in CD children, before EEN initiation, than controls 
(e.g.,  Bifi dobacterium ,  Ruminococcus , and  Faecalibacterium ). A 
similar impact was observed in OTU analysis ( Supplementary 
Table S5 ), with a large number of OTUs decreasing during EEN. For 
example, OTU3, assigned to  Bifi dobacterium, decreased in some 
children by two logs of relative abundance ( Figure 3 ), whereas 
OTU4, assigned to  R. gnavus, increased in most subjects during 
EEN ( Figure 3 ). Oligotyping of Lachnospiraceae confi rmed these 
patterns, with all oligotypes signifi cantly decreasing in abundance 
during EEN including oligotypes that were signifi cantly higher or 
lower in CD ( Supplementary Table S6 ).
 Correlations with fecal calprotectin .  We analyzed our data set 
by direct correlation to calprotectin from the same sample to 
allow proxy analysis of colonic infl ammation. Twenty-six genera 
signifi cantly correlated with calprotectin in CD children ( Supple-
mentary Table S7 ); both strong positive and negative associations 
were found. Performing stepwise regression analysis, minimizing 
the overall model Akaike Information Criterion, to determine 
which associations were most important accounting for corre-
lations between genera, seven of 14 genera were selected 
( Supplementary Table S8 ). Th e relative abundance of three 
selected genera was negatively associated with calprotectin 
( Anaerostipes ,  Coprococcus , and unknown  Erysipelotrichaceae ). 
Four were positively associated ( Bacteroides ,  Gemella ,  Haemo-
philus , and  Atopobium ). Overall, the fi nal model explained a 
remarkable 69% of the variation in fecal calprotectin concen-
tration ( Supplementary Table S8 ). A higher number of 35 
OTUs signifi cantly correlated ( Supplementary Table S9 ) with 
calprotectin, and 14 of these were selected by stepwise regression 
( Supplementary Table S10 ). Th e fi nal model predicted 78% of 
the variation in calprotectin levels among CD children. Among 
those OTUs that were most signifi cantly positively associated with 
fecal calprotectin were OTU122 ( Atopobium ), OTU1073 ( Lachno-
spiraceae ), OTU45 ( Streptococcus ), OTU1086 ( Peptostreptococcus ), 
and OTU41 ( Bacteroides ). Th ere were a number of OTUs negatively 
associated with calprotectin including OTU3 ( Bifi dobacterium ), 
OTU21 ( Lachnospiraceae ), and OTU106 ( Anaerostipes ). Using 
oligotyping, no signifi cant correlations were found between oligo-
types and calprotectin, aft er correcting for multiple comparisons.
 Genetic functional capacity using shotgun metagenomics
 Healthy children compared with CD patients before EEN .  When 
reads were assigned to metabolic KEGG modules with HUMAnN, 
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a signifi cantly larger mean Shannon diversity, in richness equiv-
alents, was observed in CD children compared with controls 
(CD vs. Controls: 48.1 vs. 43.2;  P =0.05  Figure 4 ). Healthy and 
CD children diff ered at the level of KEGG modules, with mar-
ginal signifi cance explaining 9.4% of the variation ( P =0.059; 
 Supplementary Figure S3 ). Several KEGG modules and or-
thologs ( Supplementary Table S11 ) were diff erent between the 
two groups, but their signifi cance became marginal ( P <0.100) 
when adjusted for multiple testing ( Table 3 ). Modules more 
abundant in samples from CD patients included ubiquinone and 
lipopolysaccharide biosynthesis and the twin-arginine transloca-
tion (Tat) system, whereas key processes such as fatty acid bio-
synthesis, initiation, and sulfur reduction were overrepresented in 
controls ( Table 3 ).
 Impact of EEN on CD and correlations with fecal calprotectin . 
 Four KEGG modules correlated with the number of days on EEN 
including pathways for biotin and thiamine biosynthesis (nega-
tive), the spermidine/putrescine transport system, and the shikimic 
acid pathway (positive;  Figure 4 and  Supplementary Table S12 ). 
Unlike relationships observed with taxa abundance, there were no 
signifi cant correlations between calprotectin and relative abun-
dance of KEGG modules.
 Comparison between start, end of EEN, and return to habitual 
diet
 In contrast to the impact of EEN on community structure and 
KEGG modules, there were no signifi cant changes, adjusting 
for multiple comparisons, between sample A or end of EEN (D) 
and return to habitual diet (E) for all data types (genera, OTUs, 
oligotypes, shotgun metagenomics). Although a mean increase 
in relative abundance of several taxa was observed as CD children 
returned to habitual diet, these changes were not statistically 
signifi cant. Th ose OTUs associated with fecal calprotectin 
( Supplementary Table S10 ) showed no signifi cant change, but 
it is interesting to note that those negatively associated with 
calprotectin did increase in abundance, whereas those positively 
associated in general remained low at return to the habitual diet in 
unadjusted analysis ( Supplementary Table S13 ).
 DISCUSSION
 In this study, we detailed a comprehensive sequential analysis of 
the entire fecal microbiota, its taxonomic profi le, genetic func-
tional capacity, and associations with fecal calprotectin, during 
a course of EEN in children with CD. Using a hypothesis-free 
approach, this study identifi ed various bacterial taxa associated 
with CD and other that signifi cantly changed during treatment 
with EEN. Th is study complements our previous publication of 
quantitative changes in concentration of selected bacterial metab-
olites and major bacterial groups previously implicated in the 
onset of CD.
 Several signifi cant diff erences in taxon community structure 
and relative abundance between CD children and controls were 
observed. Th e gut microbiota of CD children presented lower 
 Table 2 .  Linear regressions of genus relative abundance against 
days on EEN 
 Genus  Slope  P  value  P  value 
adjusted 
 Decreased during EEN 
  Unknown  Biﬁ dobacteriaceae 
genus 
 −0.011  7.17E−05  5.81E−03 
 Dialister  −0.0212  2.05E−04  6.12E−03 
 Biﬁ dobacterium  −0.015  2.86E−04  6.12E−03 
 Ruminococcus  −0.0159  3.02E−04  6.12E−03 
 Subdoligranulum  −0.0154  5.34E−04  7.54E−03 
  Unknown  Actinomycetaceae 
(Actinomycetales) genus 
 −0.0115  5.59E−04  7.54E−03 
 Atopobium  −0.0131  6.74E−04  7.80E−03 
 Akkermansia  −0.0155  1.02E−03  1.03E−02 
 Solobacterium  −0.0107  1.21E−03  1.09E−02 
  Unknown  Coriobacteriaceae 
genus 
 −0.00919  1.64E−03  1.33E−02 
 Megasphaera  −0.0144  1.90E−03  1.40E−02 
 Veillonella  −0.0199  3.03E−03  1.91E−02 
 Mogibacterium  −0.00849  3.75E−03  1.91E−02 
 Anaerococcus  −0.0157  3.77E−03  1.91E−02 
 Pseudobutyrivibrio  −0.0103  3.90E−03  1.91E−02 
 Peptoniphilus  −0.0137  4.04E−03  1.91E−02 
 Actinomyces  −0.0108  4.22E−03  1.91E−02 
 Prevotella  −0.0153  4.24E−03  1.91E−02 
 Staphylococcus  −0.00978  9.30E−03  3.82E−02 
 Faecalibacterium  −0.0144  1.09E−02  3.82E−02 
 Gordonibacter  −0.00958  1.10E−02  3.82E−02 
 Dorea  −0.0134  1.12E−02  3.82E−02 
 Phascolarctobacterium  −0.00807  1.12E−02  3.82E−02 
 Unknown  Veillonellaceae genus  −0.0103  1.13E−02  3.82E−02 
  Varibaculum  −0.0114  1.38E−02  4.49E−02 
  Turicibacter  −0.0111  1.61E−02  5.01E−02 
  Methanobrevibacter  −0.0118  1.69E−02  5.08E−02 
  Unknown  Akkermansiaceae 
genus 
 −0.00864  2.02E−02  5.84E−02 
  Sutterella  −0.00729  2.18E−02  6.09E−02 
  Porphyromonas  −0.00881  2.58E−02  6.96E−02 
  Unknown  Ruminococcaceae 
genus 
 −0.00685  2.66E−02  6.96E−02 
 Streptococcus  −0.00833  2.88E−02  7.30E−02 
 Rothia  −0.00915  3.27E−02  7.79E−02 
 Increased during EEN 
  Lactococcus  0.0132  3.05E−02  7.48E−02 
 EEN, exclusive enteral nutrition. 
 Linear regression of log genera abundance against days on EEN with subject-de-
pendent intercepts for the children with at least two samples. Benjamini–Hochberg 
false discovery rate was used to adjust signiﬁ cance values for multiple comparisons. 
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taxonomic diversity per individual but higher variation between 
individuals perhaps attributed to variations in disease behavior, 
location, or infl ammation severity. Shotgun metagenome analy-
sis revealed, for the fi rst time, that despite lower taxonomic bac-
terial diversity a higher level of genetic functional diversity was 
associated with the CD microbiota prior to EEN treatment. Th is 
probably refl ects a greater range of functional roles that can be 
exploited by the gut microbiota in infl amed gut, in active disease. 
Th is diverse microbial functional capacity tended to decrease dur-
ing EEN to levels similar to healthy controls. Th ese data suggest a 
higher degree of functional redundancy, with multiple species per-
forming similar roles in healthy children, and may be important in 
maintaining gut health. In active CD, this functional redundancy 
may be lost and then restored during EEN.
 Before treatment, we found bacterial taxa that were both more 
and less abundant in children with CD. Several of these fi ndings 
concur with previous work ( 2,3,6 ), but here the methodology 
employed is not only hypothesis-free, unselective of certain taxa, 
but also more comprehensive, detailing bacterial taxonomy down 
to species, OTU, and oligotype levels. Numerous OTUs and 
species were less abundant in CD children, including classic 
commensals such as  Faecalibacterium spp. and  Bifi dobacterium 
spp., but also a number of organisms that receive less attention, 
such as  Eubacterium rectale and  R. obeum. Conversely, some 
bacteria were more prevalent in CD, including  E. coli/Shigella 
spp.,  Streptococcus spp ., Peptostreptococcus spp., and  Atopobium 
spp. More interestingly, several of these diff erences were not uni-
form or of the same direction within a genus, but varied between 
species and OTUs, which emphasizes the importance and need 
for an in-depth microbiota analysis when the role of the gut 
microbiota is explored. For example,  R. gnavus was higher, but 
Ruminococcus obeum was lower in CD.
 Although the results agree with previous research ( 2,3,6 ), 
possible reverse causality complicates interpretation of their role 
in the etiology of CD. Th eir importance and the relevance of these 
fi ndings can be further unraveled only if these taxa are related to 
clinical outcomes, colonic infl ammation, or changed during the 
course of disease modifying interventions. In the current study, 
correlations between fecal calprotectin, global fecal microbial 
composition, and genetic functional capacity were explored. Sev-
eral taxa, which were diff erent between CD and controls, did not 
associate with calprotectin and may have a less protagonist role in 
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 Figure 3 .  Log abundance of OTU3 ( Biﬁ dobacterium spp. ) ( a ), OTU122 ( Atopobium spp .) ( b ), and OTU4 ( Ruminoccocus gnavus ) ( c ) as a function of days 
on EEN discriminated by subject. Adjusted  P -values: OTU122=0.0338; OTU3=0.00573; OTU4=0.0897. A full color version of this ﬁ gure is available at the 
 American Journal of Gastroenterology journal online. EEN, exclusive enteral nutrition; OTU, operational taxonomic unit.
 
© 2015 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
9
P
E
D
IA
T
R
IC
S
Fecal Metagenome and Exclusive Enteral Nutrition
99% identity in the V4 region with  Atopobium parvulum, which is 
associated with halitosis ( 11 ), and has been associated with disease 
activity in pediatric CD ( 12 ) and hence is a good candidate for fur-
ther research.
 In agreement with our previous observations using qPCR ( 6 ), 
we observed a higher abundance of  E. coli in CD. Th e  E. coli 
population is of particular interest, as adherent invasive  E. coli 
are overrepresented in CD patients ( 13 ). Moreover, the higher 
representation of KEGG modules coding for ubiquinone in CD 
children, before EEN, coincides with this observation of a higher 
relative abundance of Enterobacteriaceae. Ubiquinone is produced 
only by organisms capable of aerobic respiration, its main role is 
maintaining membrane stability by acting as a crucial membrane 
chain-terminating antioxidant. In nematodes ( 14 ), ubiquinone-
defi cient  E. coli strains were more effi  ciently lysed in the phar-
ynx or the intestine than their wild-type counterparts. Th erefore, 
ubiquinone or bacterial respiration may act as virulence factors, 
allowing bacteria to colonize and harm the host. Overrepresen-
tation of ubiquinone also fi ts with previous work ( 15 ). Likewise, 
other KEGG modules that were in higher abundance in CD, 
such as secretion and (Tat) systems, or module encoding for LPS 
the etiology of CD. Instead, we found several other that did asso-
ciate with calprotectin, negatively and positively. A subset of taxa 
was identifi ed explaining a sizable amount of the variation in fecal 
calprotectin. Among them, OTU3 ( Bifi dobacterium spp.) had the 
strongest negative and OTU122 ( Atopobium spp.) the strongest 
positive association with calprotectin in multivariate regression 
analysis.
 Treatment with EEN induced a major reduction in the rela-
tive abundance of several species, some of which were already at 
lower abundance compared with controls. Th is is a paradox, as we 
would expect EEN treatment to normalize the perceived “dysbi-
otic” microbiota toward a healthier state. Instead, EEN treatment 
shift ed the microbiota to a more “dysbiotic” state, with a greater 
NMDS distance from the healthy group compared with samples 
before EEN ( Figure 1 ). Moreover, EEN caused reduction in the 
relative abundance of gut bacteria that were negatively associ-
ated with calprotectin, as well as those that correlated positively 
with it. Among these, OTU122 ( Atopobium ) was strongly nega-
tively associated with the number of EEN days, but the commensal 
strain  Bifi dobacterium OTU3 was even more strongly negatively 
impacted. Th e particular  Atopobium OTU identifi ed, OTU122, has 
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synthesis, may be linked with overrepresentation of  Enterobacteriaceae 
or other pathobionts in CD.
 During EEN treatment, representation of KEGG modules rel-
evant to the biosynthesis of biotin and thiamine, two B-complex 
vitamins, decreased. Th is may be indicative of the reduction in 
bacteria that bear genes encoding for these vitamins during EEN, 
such as bifi dobacteria and  E. coli spp., or changes in the synthesis 
of short or medium-chain fatty acids that requires these vitamins. 
Alternatively, supply of these vitamins through EEN may induce 
bacterial redundancy or indolence to produce them. In contrast, 
genes encoding for aromatic amino acid metabolism and transport 
of spermidine/putrescine, which have a major role in cell growth, 
and may indicate increased epithelial cell renewal and tissue heal-
ing ( 16 ), were overrepresented during EEN. Against expectations, 
no association between KEGG modules and calprotectin was 
found in CD. Th is probably refl ects the lack of level in detail of cur-
rently available metabolic databases to resolve the key processes 
by which organisms impact the gut epithelium and that taxonomy 
serves as a better proxy to functional role.
 Th e observational design of this study impedes us from sug-
gesting a causative association between these fi ndings and their 
role in CD pathogenesis or indeed in proposing a mechanism of 
therapeutic action of EEN based on the changes in the gut micro-
biota. Intervention studies are required with the aim of elucidat-
ing whether maintenance of such changes, following a successful 
course of EEN, can prolong disease remission and whether replica-
 Table 3 .  Relative abundance of KEGG modules in the healthy control group and children with Crohn's before treatment with exclusive 
enteral nutrition 
 Healthy  Crohn’s disease 
 Module  Name  Mean  s.e.  Mean  s.e.  P  value  P  value adjusted 
 Decreased in CD 
 M00312  2-oxoisovalerate:ferredoxin oxidoreductase  9.96E−07  6.52E−07  3.23E−08  3.23E−08  1.37E−03  6.73E−02 
 M00082  Fatty acid biosynthesis, initiation  1.08E−06  8.56E−07  2.38E−08  1.76E−08  3.82E−03  6.73E−02 
 M00029  Urea cycle  8.05E−05  2.84E−05  9.11E−06  5.22E−06  4.64E−03  6.73E−02 
 M00030  Lysine biosynthesis  1.14E−05  4.28E−06  3.52E−06  3.24E−06  1.16E−02  9.36E−02 
 M00002  Glycolysis  4.07E−02  7.60E−04  3.68E−02  1.32E−03  1.64E−02  9.50E−02 
 M00178  Ribosome, bacteria  5.09E−02  1.10E−03  4.52E−02  1.97E−03  1.64E−02  9.50E−02 
 M00360  Aminoacyl-tRNA biosynthesis  4.21E−02  1.17E−03  3.67E−02  1.41E−03  1.64E−02  9.50E−02 
 M00361  Nucleotide sugar biosynthesis, euk.  8.02E−05  4.66E−05  6.76E−08  3.54E−08  1.64E−02  9.50E−02 
 M00362  Nucleotide sugar biosynthesis, prok.  8.69E−05  4.45E−05  1.44E−07  7.77E−08  1.64E−02  9.50E−02 
 Increased in CD 
 M00117  Ubiquinone biosynthesis  4.81E−05  4.81E−05  1.35E−03  5.24E−04  7.12E−04  6.73E−02 
 M00336  Twin-arginine translocation (Tat) system  7.03E−05  7.03E−05  1.22E−03  4.68E−04  1.70E−03  6.73E−02 
 M00060  Lipopolysaccharide biosynthesis  1.83E−04  7.82E−05  1.78E−03  4.94E−04  2.09E−03  6.73E−02 
 M00277  PTS system, N-acetylgalactosamine-speciﬁ c II component  2.49E−03  6.33E−04  6.76E−03  1.29E−03  3.13E−03  6.73E−02 
 M00019  Leucine biosynthesis  1.43E−03  6.22E−04  9.09E−03  2.03E−03  3.13E−03  6.73E−02 
 M00324  Dipeptide transport system  6.37E−04  6.40E−05  1.67E−03  3.89E−04  4.64E−03  6.73E−02 
 M00028  Ornithine biosynthesis  7.19E−03  9.57E−04  1.14E−02  1.02E−03  4.64E−03  6.73E−02 
 M00231  Octopine/nopaline transport system  3.62E−09  2.63E−09  2.40E−06  2.40E−06  6.77E−03  8.18E−02 
 M00176  Sulfur reduction, sulfate => H2S  6.04E−04  1.93E−04  1.12E−04  4.27E−05  6.77E−03  8.18E−02 
 M00276  PTS system, mannose-speciﬁ c II component  6.59E−03  8.74E−04  1.29E−02  2.21E−03  1.16E−02  9.36E−02 
 M00335  Sec (secretion) system  5.64E−04  3.53E−04  3.35E−03  1.18E−03  1.16E−02  9.36E−02 
 M00348  Glutathione transport system  1.17E-03  9.16E−05  2.11E−03  3.33E−04  1.16E−02  9.36E−02 
 M00136  GABA biosynthesis  1.04E−06  6.97E−07  3.38E−04  2.59E−04  1.16E−02  9.36E−02 
 M00050  Guanine nucleotide biosynthesis  1.62E−02  1.09E−03  2.26E−02  2.13E−03  1.16E−02  9.36E−02 
 M00260  DNA polymerase III complex  1.71E−04  1.18E−04  1.60E−03  7.21E−04  1.64E−02  9.50E−02 
 M00198  sn-Glycerol 3-phosphate transport system  2.46E−03  2.26E−04  3.99E−03  6.97E−04  1.64E−02  9.50E−02 
 CD, Crohn’s disease; EEN, exclusive enteral nutrition; GABA, gamma-aminobutyric acid; KEGG, Kyoto Encyclopedia of Genes and Genomes; PTS, phosphotransferase system. 
 Signiﬁ cance was determined using Kruskal–Wallis tests on the log relative frequencies and using Benjamini–Hochberg false discovery rate to adjust signiﬁ cance values for 
multiple comparisons; Only 25 modules with adjusted  P -value <0.1 are presented. 
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 Study Highlights
 WHAT IS CURRENT KNOWLEDGE 
 ✓  A dysbiotic microbiota with less diversity has been impli-
cated in the etiology of Crohn’s disease (CD). 
 ✓  Exclusive enteral nutrition is a ﬁ rst line treatment for ac-
tive CD in children. 
 ✓  The mode of action of exclusive enteral nutrition remains 
elusive but may be mediated by modulation of the gut 
microbiota. 
 WHAT IS NEW HERE 
 ✓  Despite disease activity improvement, exclusive enteral 
nutrition (EEN) decreased gut microbiota diversity, and the 
community structure became even more dysbiotic and dis-
similar to that of healthy controls. 
 ✓  The relative abundance of almost half of bacterial taxa 
decreased during EEN. 
 ✓  The microbiota of patients with CD had a broader function-
al capacity than that of controls, but functional diversity 
decreased with EEN. 
 ✓  Fourteen operational taxonomic units accounted for 78% 
of the variation in fecal calprotectin concentration. 
 ✓  The relative abundance of genes encoding proteins in-
volved in B-complex vitamin biosynthesis decreased at the 
end of EEN. 
 
tion of such changes occur with other types of formula and dietary 
intervention. Once this is proven, a plausible mechanism of action 
for EEN, mediated by modulation of the gut microbiota, could be 
suggested. Conversely, these changes are likely to be direct conse-
quences of a diet low in fi ber, rich in protein, fat, simple sugars and 
micronutrients, modulating various microbial communities, bac-
terial pathways, and metabolite production. Whether the clinical 
effi  cacy of EEN could be enhanced by selectively tailoring its com-
position to stimulate the growth of benefi cial microbes, suppressed 
during EEN, is also an intriguing concept to explore. Moreover, 
the very distinct CD microbiome we observed in this study may 
hold implications for improvement in diagnostic and prognostic 
classifi cation of the disease, particularly in conjunction with other 
established disease biomarkers such as fecal calprotectin.
 Th is study has some limitations. We performed analysis in feces, 
enabling a non-invasive collection of serial samples, but results 
may diff er from mucosal adherent bacteria. Despite correcting 
for multiple testing, our participant’s sample size was modest, and 
this study may be underpowered to explore secondary outcomes 
such as associations between disease location and behavior with 
microbiota characteristics. Also, as a community expresses only 
a variable subset of its genome, at any time, metatranscriptomic 
and metabolomic data are required to complement and progress 
this work further. Some patients were on concomitant treatment, 
and there was a modest age diff erence between controls and CD 
children. However, any eff ect was minimal with the changes dem-
onstrated driven predominantly by EEN or diff erences accord-
ing to grouping (CD vs. Healthy) on community structure. Th is 
reconfi rms evidence that diet is a strong determinant of the micro-
bial microenvironment ( 17 ). Although PCDAI and CRP were 
highly correlated with fecal calprotectin ( r =0.60;  P =7.924×10 −06 
and  r =0.42;  P =4.644×10 −03 ), we preferred to use and present data 
only for the latter, an observer-independent and reliable marker of 
colonic infl ammation, as this study aimed specifi cally to associate 
a direct marker of colonic infl ammation with microbiota composi-
tion and functional capacity measured in the same fecal sample. 
Moreover, preliminary analysis showed that fecal calprotectin was 
a better predictor of community structure explaining 10.5% of the 
variation in genus relative abundances across these samples com-
pared with 9.3% and 3.5% for the PCDAI scores and CRP values, 
respectively.
 Although there is still a degree of reverse causality to address 
even with the methodological approach applied here, this study 
successfully removed a great deal of “microbial signal noise”, poten-
tially irrelevant to the microbial origins of CD, and thus focuses 
the fi eld for more targeted research. Future interventions aiming 
to induce or maintain EEN-induced changes in the gut microbiota 
are needed to elucidate the signifi cance of these observed changes 
in the etiology of CD and mechanism of action of EEN.
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